Detalles de la búsqueda
1.
Antagonism of Ang-Tie2 and Dll4-Notch signaling has opposing effects on tumor endothelial cell proliferation, evidenced by a new flow cytometry method.
Lab Invest
; 94(11): 1296-308, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25243900
2.
Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockade.
J Immunother Cancer
; 11(5)2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37156551
3.
Infusion Product TNFα, Th2, and STAT3 Activities Are Associated with Clinical Responses to Transgenic T-cell Receptor Cell Therapy.
Cancer Immunol Res
; 11(12): 1589-1597, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37871333
4.
Measurement of conatumumab-induced apoptotic activity in tumors by fine needle aspirate sampling.
Cytometry A
; 77(9): 849-60, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20623688
5.
A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma.
J Immunother
; 43(9): 273-282, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32925563
6.
Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitors.
Bioorg Med Chem Lett
; 19(22): 6307-12, 2009 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19819693
7.
A Pilot Trial of the Combination of Transgenic NY-ESO-1-reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab.
Clin Cancer Res
; 25(7): 2096-2108, 2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30573690
8.
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer.
Cell Stem Cell
; 25(4): 542-557.e9, 2019 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31495780
9.
IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune System.
Clin Cancer Res
; 25(3): 1000-1011, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30409823
10.
Discovery and optimization of triazolopyridazines as potent and selective inhibitors of the c-Met kinase.
J Med Chem
; 51(10): 2879-82, 2008 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-18426196
11.
Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products.
J Immunother
; 41(5): 248-259, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29470191
12.
Identification of genes potentially involved in the acquisition of androgen-independent and metastatic tumor growth in an autochthonous genetically engineered mouse prostate cancer model.
Prostate
; 67(1): 83-106, 2007 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17013881
13.
A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model.
Oncogene
; 24(29): 4736-40, 2005 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-15870705
14.
In Vitro and In Vivo Activity of AMG 337, a Potent and Selective MET Kinase Inhibitor, in MET-Dependent Cancer Models.
Mol Cancer Ther
; 15(7): 1568-79, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27196782
15.
PD-1 Blockade Expands Intratumoral Memory T Cells.
Cancer Immunol Res
; 4(3): 194-203, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26787823
16.
Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma.
Clin Cancer Res
; 20(9): 2457-65, 2014 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24634374
17.
Characterization of 64Cu-DOTA-conatumumab: a PET tracer for in vivo imaging of death receptor 5.
J Nucl Med
; 52(6): 942-9, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21571804
18.
Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor types.
Cancer Biol Ther
; 9(8): 618-31, 2010 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20150762
19.
Safety, pharmacokinetics, and pharmacodynamics of AMG 102, a fully human hepatocyte growth factor-neutralizing monoclonal antibody, in a first-in-human study of patients with advanced solid tumors.
Clin Cancer Res
; 16(2): 699-710, 2010 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20068101
20.
Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium.
Cancer Res
; 68(9): 3495-504, 2008 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18451178